- About
- PsychU For You
- Topics
- Events
- Content
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
In this presentation, the objectives are to:
- Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
- Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
- Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder
David Purselle, MD
Board-certified psychiatrist with over 20 years of clinical experience, Director of Georgia Psychiatric Consultants and an adjunct faculty member at Morehouse School of Medicine
MoreDr. David Purselle is a board-certified psychiatrist with over 20 years of clinical experience working in a variety of settings, including outpatient clinics, emergency rooms, and inpatient units at the Atlanta VA Medical Center, Emory University Hospital, and Grady Hospital. Currently, he is the Director of Georgia Psychiatric Consultants and an adjunct faculty member at Morehouse School of Medicine. He is also involved with several clinical research studies studying the effectiveness of various antidepressants, mood stabilizers, antipsychotics, and lithium. Dr. Purselle has been recognized as a physician leader in several forums and presented continuing medical education programs at national and local conferences. He has also served as a consultant for major pharmaceutical corporations providing guidance on development of new therapies for a variety of mental illnesses.
Kayci Criss, PharmD
David Purselle, MD is a speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Kayci Criss, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
Registration
- PsychU For You
